These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 2858363)

  • 1. Famotidine, a new H2-receptor antagonist. Effect on parietal, nonparietal, and pepsin secretion in man.
    Smith JL; Gamal MA; Chremos AN; Graham DY
    Dig Dis Sci; 1985 Apr; 30(4):308-12. PubMed ID: 2858363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of famotidine.
    Smith JL
    Digestion; 1985; 32 Suppl 1():15-23. PubMed ID: 2866132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MK-208, a novel histamine H2-receptor inhibitor with prolonged antisecretory effect.
    McCallum RW; Chremos AN; Kuljian B; Tupy-Visich MA; Huber PB
    Dig Dis Sci; 1985 Dec; 30(12):1139-44. PubMed ID: 2866073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine on pentagastrin-stimulated gastric secretion in healthy man.
    Aadland E; Berstad A; Semb LS
    Scand J Gastroenterol; 1977; 12(4):501-6. PubMed ID: 18791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in Heidenhain pouch dogs (author's transl)].
    Ohtsuki H; Okabe S
    Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):539-47. PubMed ID: 6120885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of gastric secretion in man with a new H2-receptor antagonist, ranitidine.
    Kett K; Aadland E; Berstad A
    Scand J Gastroenterol; 1980; 15(2):249-51. PubMed ID: 6104355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of cimetidine on histamine- and pentagastrin-stimulated gastric secretion in healthy subjects.
    Aadland E; Berstad A
    Scand J Gastroenterol; 1979; 14(3):367-72. PubMed ID: 375377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in rats: comparison with cimetidine (author's transl)].
    Okabe S; Kawakami M
    Nihon Yakurigaku Zasshi; 1981 Aug; 78(2):57-62. PubMed ID: 6119281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
    Hammond JB; Offen WW
    Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of ranitidine and famotidine with guinea pig-isolated parietal cells.
    Sewing KF; Hannemann H
    Pharmacology; 1986; 33(5):274-8. PubMed ID: 2432626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological evaluation of cimetidine, a new histamine H2-receptor antagonist, in healthy man.
    Burland WL; Duncan WA; Hesselbo T; Mills JG; Sharpe PC; Haggie SJ; Wyllie JH
    Br J Clin Pharmacol; 1975 Dec; 2(6):481-6. PubMed ID: 9952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of antisecretory action of a new H2-antagonist, YM-11170, in conscious dogs.
    Takeda M; Takagi T; Maeno H
    Eur J Pharmacol; 1983 Aug; 91(4):371-6. PubMed ID: 6137398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study with ranitidine and cimetidine on gastric secretion in normal volunteers.
    Sewing KF; Billian A; Malchow H
    Gut; 1980 Sep; 21(9):750-2. PubMed ID: 6107265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a histamine H2-receptor antagonist, famotidine, on gastric secretion in healthy subjects.
    Fukuda Y; Ikezoe I; Okabayashi M; Ohama I; Shimoyama T
    Clin Ther; 1987; 9(5):528-35. PubMed ID: 2889528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of gastric secretion by a new H2-antagonist, YM-11170 in healthy subjects.
    Miwa M; Tani N; Miwa T
    Int J Clin Pharmacol Ther Toxicol; 1984 Apr; 22(4):214-7. PubMed ID: 6325352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of H2-receptor antagonists upon physiological acid secretory states in animals.
    Pendleton RG; Cook PG; Shepherd-Rose A; Mangel AW
    J Pharmacol Exp Ther; 1985 Apr; 233(1):64-9. PubMed ID: 2858583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
    Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
    Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of structurally different H2-antagonists on acid and pepsin activity stimulated by dimaprit in conscious cats.
    Impicciatore M; Chiavarini M; Morini G; Barocelli E; Molina E; Plazzi PV
    Agents Actions; 1985 Sep; 16(6):496-500. PubMed ID: 2866688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Furan H2-antagonist ranitidine inhibits pentagastrin-stimulated gastric secretion stronger than cimetidine.
    Domschke W; Lux G; Domschke S
    Gastroenterology; 1980 Dec; 79(6):1267-71. PubMed ID: 6108279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cimetidine on pentagastrin-stimulated gastric acid and pepsin secretion before and after 6 weeks of cimetidine treatment.
    Aadland E; Berstad A
    Scand J Gastroenterol; 1978; 13(2):193-7. PubMed ID: 345415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.